When scaling after major financing, a people strategy must balance three priorities: protecting the core cultural elements that drive success, evolving processes with more rigor to enable scale, and maintaining strict discipline on organizational design to prevent bloated hiring and remain lean.
Leadership during rapid scaling involves navigating inherent tensions that cannot be solved, only managed. These paradoxes include balancing ambition with focus, preserving legacy culture while embracing new ideas, and driving execution while also building trust with a wave of new hires.
To thrive in the volatile biotech industry, employees need more than resilience. They must understand the broader context, from the drug development value chain to the patient's healthcare journey. This systemic view helps them understand the 'why' behind the inevitable strategic pivots, fostering adaptability.
As technology and AI automate transactional tasks, the most scarce and valuable capabilities for HR professionals will be those that are uniquely human. This includes skills like applying empathy, reading interpersonal dynamics to navigate conflict, and coaching individuals through difficult situations.